Optimi Health Corp. · CSE:OPTI
Optimi Health — IPO Roadshow (January 2021)
22 slides from Optimi Health's IPO roadshow presentation, Jan 15, 2021
Slide 1: Welcome to the future of human optimization
welcome to the future of human optimization January 15, 2021
Slide 2: Legal Disclaimer
Legal Disclaimer The information contained in this presentation is provided by Optimi Health Corp. (“Optimi” or the “Company”) for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an over to issue, securities of Optimi or other financi
Slide 3: Highlights
Highlights PREMIUM STRATEGIC WORLD CLASS PASSIONATE STRATEGIC EXCEPTIONAL EXPERIENCED PREMIUM BUSINESS CULTIVATION & PASSIONATE NUTRACEUTICALS ADVANTAGES FACILITIES TEAM CTC OPPORTUNITY • Vertically integrated operation: • In-house Health Canada consulting • Strong Advisory Team supporting all • Sub
Slide 4: Transforming identity through human optimization
transforming identity through human optimization Optimi Health believes that personal identity is a fluid and evolving aspect of all our lives and encompasses our physical, spiritual and mental well-being.
Slide 5: Why Mushrooms?
Why Mushrooms? 6% THE GLOBAL FUNCTIONAL Functional Mushrooms that drive the Market ANNUAL MUSHROOM MARKET GROWTH IS GROWING Chaga, Reishi, Lion’s Mane and Cordyceps extracts are the most popular functional mushrooms. 34B Advanced expertise and ongoing $ FORECAST TO $34 BILLION GLOBALLY research help
Slide 6: Why Now?
Why Now? The Functional Mushroom and Mushroom Nutraceutical blends are Market is Growing simply more appealing. The global functional mushroom market is Blends have a higher average cost per serving growing at 6% annually, netting to $34B compared to pure mushroom products. globally by 2025 with $18
Slide 7: Our Team
Our Team Bryan Safarik Jacob Safarik Mike Stier COO & DIRECTOR CFO CEO & DIRECTOR Over fifteen years of experience in Senior Over 12 years of experience in accounting, Following Mike’s studies in business Management roles, as well as Founder project finance, business development management & finance
Slide 8: Our Advisors
Our Advisors Chip Wilson Edward Safarik Harley Pasternak ADVISOR ADVISOR ADVISOR Chip Wilson is a Canadian businessman Edward is a Member in good standing of As a fitness and nutrition specialist, and philanthropist, who has founded the Law Society of British Columbia and Mr. Pasternak’s client rost
Slide 9: The Industry & Optimi
The Industry & Optimi Limited Differentiated Better Competition to Products: Extraction Grow Fruiting Processes: Bodies: Almost no competitors Fruiting Bodies offer higher Throughout the industry alcohol currently growing and selling purity and net 35% higher and hot water extraction fruiting bodies
Slide 10: Nutraceutical Products
Nutraceutical Products Optimi Products for an Optimized Lifestyle MINDFUL MUSHROOM IMMUNITY MUSHROOM LONGEVITY MUSHROOM CAPSULE CAPSULE CAPSULE LIMITLESS VEGAN PROTEIN Lion’s Mane is used by high Turkey Tail is one of the most The Longevity capsules are here to performance individuals looking to com
Slide 11: Functional Ingredients
There are 5 mushrooms in particular that are gaining significant Functional Ingredients popularity, each with clinically proven benefits that can be used in isolation, or together for an holistic approach to wellness. Optimi Health’s highly sought-after range of fungi varieties includes: LIONS MANE
Slide 12: The Future
The Future Pharmaceutical Grade Medicinal (Current) Psilocybin Products: ANXIETY (high growth segment) Through the research partnership, Optimi DEPRESSION has immediate access to a large, and legal, (mental health is very commonly overlooked) patient base to run clinical trials. ADDICTION (smoking,
Slide 13: Psilocybin Research
Optimi Health’s application to Health Canada is underway and if approved, paves the way to pilot cultivation, Psicolcybin Research advanced research and development, control studies, peer review registry and a significant competitive timeline advantage towards pharmaceutical industry applications. C
Slide 14: Business Divisions: Optimi Farms Facility One
Business Divisions Optimi Farms FACILITY ONE: OPTIMI FUNCTIONAL Optimi Farms Facility #1 is focused on growing high demand functional mushroom varieties such as Lion’s Mane, Reishi, Turkey Tail and Cordyceps. Operational Considerations: • Immediate sales of Canadian grown functional mushrooms • Effi
Slide 15: Business Divisions: Optimi Farms Facility Two
Business Divisions Optimi Farms FACILITY TWO: OPTIMI DEVELOPMENTAL Optimi Farms Facility #2 is designed to accommodate either functional mushroom or pharmaceutical grade production (GMP) of functional or psychoactive mushrooms (i.e. containing psilocybin), and is intended to service both large scale
Slide 16: Business Divisions: Optimi Labs
Business Divisions Optimi Labs KEY FUNCTIONS • Optimize commercial cultivation processes • Improve strain quality & yield • Improve extraction efficiencies • Fungi extract innovation • Product development • Innovation in human delivery mechanisms • Synthetic and non-synthetic compound exploration •
Slide 17: The Functional Opportunity
The Functional Opportunity Broad Functional mushroom benefits range from improved physical to Health mental wellness (stress resistance). From a select base of key mushroom strains Optimi Farm aims to deliver products with a Benefits: broad range of benefits. Ongoing scientific and market research c
Slide 18: Summary
Summary Pre-operational Cultivation Strategically Multiple Facilities -to- Located Revenue Constructed Consumer Generating Assets in Development Optimi Health is preparing From supplements Welcome to Offering diversity and to launch its business and nutraceuticals, to business-friendly and the found
Slide 19: Comparable Companies
Comparable Companies Company Ticker Market Cultivation/ Clinics/ OPERATIONS Functional Research Dealers Phase of DRUG DEVELOPMENT Primary Primary Cap Processing Retreats Mushrooms Exemption License Primary Psychedelic Indication ($MM) Clinical Trial Compound Psychedelics - Drug Development & Functio
Slide 20: Capitalization Table
Capitalization Table OPTIMI HEALTH CORP. Canadian Securities Exchange IPO - January 2021 Capitalization Table SHARES CASH PRICE Founders & Management 20,000,000 $1,000,000 Family & Friends Seed Round 17,963,005 $4,490,751 $0.25 Pre IPO 37,963,005 $5,490,751 Warrants Founders & Management 10,000,000
Slide 21: Optimi Source & Use of Funds
Optimi Source & Use of Funds OPTIMI HEALTH CORP. Source and Use of Funds IPO financing - January 2021 We intend to use the existing working capital and net proceeds from the Offering as follows: Use of Available Funds Estimated Amount Estimated Amount to be Expended to be Expended (Minimum Offering)
Slide 22: Thank You
THANK YOU OPTIMI HEALTH CORP. 201 - 1448 Commercial Drive Vancouver BC V5L 3X9 E. info@optimihealth.ca T. 778 930-1321